Form 4 for CGTX COGNITION THERAPEUTICS INC
Accepted 2023-05-03 00:00:00 ET · period of report 2023-05-01 · accession 0001062993-23-010091 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-05-03 | 2023-05-01 | CGTX | Doyle John Brendan | CFO | A - Grant | $0.00 | +109.8K | 109.8K | New | $0 |
| D | 2023-05-03 | 2023-05-01 | CGTX | Doyle John Brendan | CFO | A - Grant | $0.00 | +109.8K | 109.8K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-05-01 | A | A | 109,824 | $0.00 | 109,824 | D | — | — | (F1) Each share is represented by a restricted stock unit ("RSU"). Each RSU represents a contingent right to receive one share of the Issuer's Common Stock upon settlement. |
| 2 | Derivative | Stock Option (right to buy) | 2023-05-01 | A | A | 109,824 | $0.00 | 109,824 | D | $1.65 · — to 2033-05-01 | 109,824 Common Stock | (F2) The option vests 25% on May 1, 2024, with the remaining 75% vesting in 36 equal monthly installments, subject to the Reporting Person's continued service through the applicable vesting dates. |